These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34283610)

  • 21. Tellurides bearing benzensulfonamide as carbonic anhydrase inhibitors with potent antitumor activity.
    Angeli A; Pinteala M; Maier SS; Toti A; Di Cesare Mannelli L; Ghelardini C; Selleri S; Carta F; Supuran CT
    Bioorg Med Chem Lett; 2021 Aug; 45():128147. PubMed ID: 34052322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer.
    Zhang W; Zhang K; Yao Y; Liu Y; Ni Y; Liao C; Tu Z; Qiu Y; Wang D; Chen D; Qiang L; Li Z; Jiang S
    Eur J Med Chem; 2021 Feb; 211():113022. PubMed ID: 33239261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
    An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V
    Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.
    Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM
    Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII.
    Bua S; Lomelino C; Murray AB; Osman SM; ALOthman ZA; Bozdag M; Abdel-Aziz HA; Eldehna WM; McKenna R; Nocentini A; Supuran CT
    J Med Chem; 2020 Jan; 63(1):321-333. PubMed ID: 31794211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
    Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
    Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
    Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
    Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
    Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116.
    Samad MA; Saiman MZ; Abdul Majid N; Karsani SA; Yaacob JS
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33450878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
    Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
    Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
    Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII.
    Ibrahim HS; Abou-Seri SM; Tanc M; Elaasser MM; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2015 Oct; 103():583-93. PubMed ID: 26408817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.